Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.30p
   
  • Change Today:
    -0.20p
  • 52 Week High: 36.43
  • 52 Week Low: 5.59
  • Currency: UK Pounds
  • Shares Issued: 585.67m
  • Volume: 2,375,355
  • Market Cap: 36.90m

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

1 Day Chart (02-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1313.5% -227.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 24.3 4.7
Pr/Book 0.9  
Latest F'cast
Revenue -85.4% 440.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

STX Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 0.64 (20.99) (16.05)p n/a n/a n/a n/a 0.0%
31-Dec-18 11.88 (5.15) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.72 (9.07) (7.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.57) (8.74)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

STX Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 8.20 (18.66) (7.84)p n/a n/a n/a n/a 0.0%
31-Dec-23 29.01 (22.29) (4.62)p n/a n/a n/a n/a 0.0%
31-Dec-24 79.34 6.50 (0.35)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

STX Company Announcements

Holding(s) in Company 13-Jan-2023 10:30 RNS
Holding(s) in Company 12-Jan-2023 14:40 RNS
Holding(s) in Company 12-Jan-2023 14:15 RNS

Latest STX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

STX Market Data

Currency UK Pounds
Share Price 6.30p
Change Today -0.20p
% Change -3.08 %
52 Week High 36.43
52 Week Low 5.59
Volume 2,375,355
Shares Issued 585.67m
Market Cap 36.90m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.81% above the market average18.81% above the market average18.81% above the market average18.81% above the market average18.81% above the market average
68.97% above the sector average68.97% above the sector average68.97% above the sector average68.97% above the sector average68.97% above the sector average
Price Trend
85.83% below the market average85.83% below the market average85.83% below the market average85.83% below the market average85.83% below the market average
67.74% below the sector average67.74% below the sector average67.74% below the sector average67.74% below the sector average67.74% below the sector average
Income Not Available
Growth
21.20% above the market average21.20% above the market average21.20% above the market average21.20% above the market average21.20% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average

STX Dividends

No dividends found

Trades for 02-Feb-2023

Time Volume / Share Price
16:35 17,169 @ 6.30p
16:35 2,169 @ 6.30p
16:35 5,456 @ 6.30p
16:35 9,544 @ 6.30p
16:31 150,000 @ 6.30p

Top of Page